Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-12-23 | New | $10,557,600 | $10,557,600 | Equity Only | 06b | SEC link |
| 2023-04-14 | New | $7,064,364 | $7,064,364 | Debt Only | 06b | SEC link |
| 2022-08-15 | Amended | $27,969,129 | $2,900,000 | Debt Only | 06b | SEC link |
| 2022-05-06 | Amended | $25,069,129 | $12,673,000 | Debt Only | 06b | SEC link |
| 2021-09-15 | Amended | $12,396,129 | $4,270,000 | Debt Only | 06b | SEC link |
| 2020-12-10 | New | $8,126,129 | $8,126,129 | Debt Only | 06b | SEC link |
| 2019-08-16 | New | $15,900,000 | $15,900,000 | Equity Only | 06b | SEC link |
| 2018-01-04 | New | $4,500,000 | $4,500,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Eric Atkins | Executive |
| Gail Becker | Director |
| Robert Dahl | Director |
| W. Robert Dahl | Director |
| Cynthia Eckert | Director, Executive |
| Margaret Henry | Executive |
| Sandra Mc Glothlin | Director |
| Adele Oliva | Director |
| Matthew Petzold | Executive |
| Cynthia Whitehead | Director, Executive |
| Robert Whitehead | Director |